HK Stock MarketDetailed Quotes

01858 CHUNLI MEDICAL

Watchlist
  • 9.400
  • +0.070+0.75%
Market Closed Mar 28 16:08 CST
3.61BMarket Cap11.76P/E (TTM)

CHUNLI MEDICAL Key Stats

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
(Q9)Sep 30, 2021
Turnover
0.58%1.21B
4.24%792.16M
-5.37%540.71M
-4.18%246.36M
8.43%1.2B
5.79%759.96M
18.39%571.39M
13.45%257.11M
18.18%1.11B
--718.39M
Operating income
0.58%1.21B
4.24%792.16M
-5.37%540.71M
-4.18%246.36M
8.43%1.2B
5.79%759.96M
18.39%571.39M
13.45%257.11M
18.18%1.11B
718.39M
Operating expenses
-15.47%-332.64M
-17.08%-232.37M
-2.55%-149.3M
-55.17%-77.92M
-13.60%-288.08M
-18.58%-198.48M
-28.42%-145.59M
11.35%-50.21M
1.30%-253.6M
-167.38M
Gross profit
-4.12%875.89M
-0.30%559.78M
-8.08%391.41M
-18.59%168.44M
6.90%913.53M
1.90%561.49M
15.31%425.8M
21.72%206.9M
25.53%854.54M
551.02M
Selling expenses
2.13%-383.14M
-1.56%-233.75M
-7.66%-166.89M
18.69%-64.97M
-14.45%-391.47M
1.55%-230.17M
-8.68%-155.01M
-24.04%-79.9M
-41.92%-342.05M
---233.8M
Administrative expenses
-14.50%-44.47M
-17.15%-28.91M
-22.59%-18.96M
-17.28%-7.05M
-26.63%-38.84M
-15.36%-24.68M
-13.54%-15.46M
-8.06%-6.01M
1.76%-30.67M
---21.39M
Research and development expenses
3.02%-157.45M
-9.26%-114.74M
-3.16%-74.57M
-0.47%-33.27M
-54.84%-162.34M
-61.11%-105.01M
-111.19%-72.29M
-124.70%-33.11M
-44.41%-104.84M
---65.18M
Profit from asset sales
-84.57%3.9K
-102.17%-549.43
----
----
70.33%25.31K
70.33%25.31K
208.84%25.31K
208.84%25.31K
109.39%14.86K
--14.86K
Revaluation surplus
1.27%9.61M
8.14%7.07M
10.60%4.38M
19.29%2.02M
--9.49M
--6.54M
--3.96M
--1.7M
----
----
-Changes in the fair value of other assets
1.27%9.61M
8.14%7.07M
10.60%4.38M
19.29%2.02M
--9.49M
--6.54M
--3.96M
--1.7M
----
----
Impairment and provision
17.33%-25.02M
14.50%-11.48M
28.70%-11.96M
-58.09%-7.95M
-10.91%-30.27M
-4.13%-13.43M
-63.90%-16.78M
16.95%-5.03M
-338.47%-27.29M
---12.89M
-Other impairment is provision
17.33%-25.02M
14.50%-11.48M
28.70%-11.96M
-58.09%-7.95M
-10.91%-30.27M
-4.13%-13.43M
-63.90%-16.78M
16.95%-5.03M
-338.47%-27.29M
---12.89M
Special items of operating profit
13.14%24.82M
-47.15%15.19M
128.98%14.08M
567.34%5.45M
25.68%21.94M
85.95%28.73M
-54.22%6.15M
-28.20%816.85K
108.45%17.45M
--15.45M
Operating profit
-6.26%289.39M
-12.73%187.42M
-20.96%133.47M
-26.22%61.14M
-13.75%308.73M
-5.28%214.75M
-4.64%168.86M
5.32%82.87M
8.98%357.95M
226.72M
Financing cost
-17.81%16.58M
-48.62%8.52M
-13.57%4.99M
-14.82%1.2M
109.24%20.17M
94.68%16.58M
8.00%5.78M
-63.31%1.41M
489.13%9.64M
--8.52M
Special items of earning before tax
-100.87%-69.6K
97.78%-49.92K
103.46%77.61K
91.23%-116.59K
3,843.45%7.97M
-1,295.24%-2.25M
-1,126.43%-2.24M
-895.46%-1.33M
14.47%-212.93K
---161.28K
Earning before tax
-9.19%305.91M
-14.49%195.88M
-19.64%138.54M
-24.99%62.23M
-8.30%336.88M
-2.55%229.07M
-5.41%172.4M
0.68%82.95M
11.38%367.38M
235.07M
Tax
3.68%-28.09M
20.47%-15.4M
18.57%-12.55M
28.73%-6.36M
35.22%-29.16M
37.32%-19.37M
42.26%-15.41M
35.79%-8.93M
3.13%-45.02M
---30.9M
After-tax profit from continuing operations
-9.72%277.82M
-13.94%180.48M
-19.75%125.99M
-24.53%55.86M
-4.54%307.72M
2.71%209.71M
0.92%156.98M
8.09%74.02M
13.76%322.36M
204.18M
Earning after tax
-9.72%277.82M
-13.94%180.48M
-19.75%125.99M
-24.53%55.86M
-4.54%307.72M
2.71%209.71M
0.92%156.98M
8.09%74.02M
13.76%322.36M
204.18M
Minority profit
---5.9K
---142.39K
---91.88K
----
----
----
----
----
----
----
Profit attributable to shareholders
-9.72%277.82M
-13.87%180.62M
-19.69%126.08M
-24.53%55.86M
-4.54%307.72M
2.71%209.71M
0.92%156.98M
8.09%74.02M
13.76%322.36M
204.18M
Basic earnings per share
-10.00%0.72
-14.55%0.47
-19.51%0.33
-21.05%0.15
-13.98%0.8
-6.78%0.55
-8.89%0.41
-5.00%0.19
13.41%0.93
0.59
Diluted earnings per share
-10.00%0.72
-14.55%0.47
-19.51%0.33
-21.05%0.15
-13.98%0.8
-6.78%0.55
-8.89%0.41
-5.00%0.19
13.41%0.93
0.59
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
Auditor
--
--
--
--
Daishin Certified Public Accountants (Special General Partnership)
--
--
--
Daishin Certified Public Accountants (Special General Partnership)
--
(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021(Q9)Sep 30, 2021
Turnover 0.58%1.21B4.24%792.16M-5.37%540.71M-4.18%246.36M8.43%1.2B5.79%759.96M18.39%571.39M13.45%257.11M18.18%1.11B--718.39M
Operating income 0.58%1.21B4.24%792.16M-5.37%540.71M-4.18%246.36M8.43%1.2B5.79%759.96M18.39%571.39M13.45%257.11M18.18%1.11B718.39M
Operating expenses -15.47%-332.64M-17.08%-232.37M-2.55%-149.3M-55.17%-77.92M-13.60%-288.08M-18.58%-198.48M-28.42%-145.59M11.35%-50.21M1.30%-253.6M-167.38M
Gross profit -4.12%875.89M-0.30%559.78M-8.08%391.41M-18.59%168.44M6.90%913.53M1.90%561.49M15.31%425.8M21.72%206.9M25.53%854.54M551.02M
Selling expenses 2.13%-383.14M-1.56%-233.75M-7.66%-166.89M18.69%-64.97M-14.45%-391.47M1.55%-230.17M-8.68%-155.01M-24.04%-79.9M-41.92%-342.05M---233.8M
Administrative expenses -14.50%-44.47M-17.15%-28.91M-22.59%-18.96M-17.28%-7.05M-26.63%-38.84M-15.36%-24.68M-13.54%-15.46M-8.06%-6.01M1.76%-30.67M---21.39M
Research and development expenses 3.02%-157.45M-9.26%-114.74M-3.16%-74.57M-0.47%-33.27M-54.84%-162.34M-61.11%-105.01M-111.19%-72.29M-124.70%-33.11M-44.41%-104.84M---65.18M
Profit from asset sales -84.57%3.9K-102.17%-549.43--------70.33%25.31K70.33%25.31K208.84%25.31K208.84%25.31K109.39%14.86K--14.86K
Revaluation surplus 1.27%9.61M8.14%7.07M10.60%4.38M19.29%2.02M--9.49M--6.54M--3.96M--1.7M--------
-Changes in the fair value of other assets 1.27%9.61M8.14%7.07M10.60%4.38M19.29%2.02M--9.49M--6.54M--3.96M--1.7M--------
Impairment and provision 17.33%-25.02M14.50%-11.48M28.70%-11.96M-58.09%-7.95M-10.91%-30.27M-4.13%-13.43M-63.90%-16.78M16.95%-5.03M-338.47%-27.29M---12.89M
-Other impairment is provision 17.33%-25.02M14.50%-11.48M28.70%-11.96M-58.09%-7.95M-10.91%-30.27M-4.13%-13.43M-63.90%-16.78M16.95%-5.03M-338.47%-27.29M---12.89M
Special items of operating profit 13.14%24.82M-47.15%15.19M128.98%14.08M567.34%5.45M25.68%21.94M85.95%28.73M-54.22%6.15M-28.20%816.85K108.45%17.45M--15.45M
Operating profit -6.26%289.39M-12.73%187.42M-20.96%133.47M-26.22%61.14M-13.75%308.73M-5.28%214.75M-4.64%168.86M5.32%82.87M8.98%357.95M226.72M
Financing cost -17.81%16.58M-48.62%8.52M-13.57%4.99M-14.82%1.2M109.24%20.17M94.68%16.58M8.00%5.78M-63.31%1.41M489.13%9.64M--8.52M
Special items of earning before tax -100.87%-69.6K97.78%-49.92K103.46%77.61K91.23%-116.59K3,843.45%7.97M-1,295.24%-2.25M-1,126.43%-2.24M-895.46%-1.33M14.47%-212.93K---161.28K
Earning before tax -9.19%305.91M-14.49%195.88M-19.64%138.54M-24.99%62.23M-8.30%336.88M-2.55%229.07M-5.41%172.4M0.68%82.95M11.38%367.38M235.07M
Tax 3.68%-28.09M20.47%-15.4M18.57%-12.55M28.73%-6.36M35.22%-29.16M37.32%-19.37M42.26%-15.41M35.79%-8.93M3.13%-45.02M---30.9M
After-tax profit from continuing operations -9.72%277.82M-13.94%180.48M-19.75%125.99M-24.53%55.86M-4.54%307.72M2.71%209.71M0.92%156.98M8.09%74.02M13.76%322.36M204.18M
Earning after tax -9.72%277.82M-13.94%180.48M-19.75%125.99M-24.53%55.86M-4.54%307.72M2.71%209.71M0.92%156.98M8.09%74.02M13.76%322.36M204.18M
Minority profit ---5.9K---142.39K---91.88K----------------------------
Profit attributable to shareholders -9.72%277.82M-13.87%180.62M-19.69%126.08M-24.53%55.86M-4.54%307.72M2.71%209.71M0.92%156.98M8.09%74.02M13.76%322.36M204.18M
Basic earnings per share -10.00%0.72-14.55%0.47-19.51%0.33-21.05%0.15-13.98%0.8-6.78%0.55-8.89%0.41-5.00%0.1913.41%0.930.59
Diluted earnings per share -10.00%0.72-14.55%0.47-19.51%0.33-21.05%0.15-13.98%0.8-6.78%0.55-8.89%0.41-5.00%0.1913.41%0.930.59
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --------Unqualified Opinion------Unqualified Opinion--
Auditor --------Daishin Certified Public Accountants (Special General Partnership)------Daishin Certified Public Accountants (Special General Partnership)--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg